{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:06:16Z","timestamp":1776524776168,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12029-021-00709-8","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T05:02:58Z","timestamp":1631682178000},"page":"915-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management and Survival Analysis of Gastrointestinal Neuroendocrine Tumors by Different Tumor Characteristics: Tertiary Center Experience"],"prefix":"10.1007","volume":"53","author":[{"given":"Bedia","family":"Gonulal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-5548","authenticated-orcid":false,"given":"Yilmaz","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine Turkmen","family":"Samdanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"709_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1159\/000085237","volume":"80","author":"Pl\u00f6ckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B; European Neuroendocrine Tumour Society","year":"2004","unstructured":"Pl\u00f6ckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B. European Neuroendocrine Tumour Society. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004;80:394\u2013424. https:\/\/doi.org\/10.1159\/000085237.","journal-title":"Neuroendocrinology."},{"key":"709_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7150\/jca.4502","volume":"3","author":"VL Tsikitis","year":"2012","unstructured":"Tsikitis VL, Wertheim BC, Guerrero MA. Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis. J Cancer. 2012;3:292\u2013302. https:\/\/doi.org\/10.7150\/jca.4502.","journal-title":"J Cancer."},{"key":"709_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000441897","volume":"104","author":"I Huguet","year":"2017","unstructured":"Huguet I, Grossman AB, O\u2019Toole D. Changes in the epidemiology of neuroendocrine tumours. Neuroendocrinology. 2017;104:105\u201311. https:\/\/doi.org\/10.1159\/000441897.","journal-title":"Neuroendocrinology."},{"key":"709_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol."},{"key":"709_CR5","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/cncr.23883","volume":"113","author":"O Hauso","year":"2008","unstructured":"Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655\u201364. https:\/\/doi.org\/10.1002\/cncr.23883.","journal-title":"Cancer."},{"key":"709_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/COC.0b013e31807a2f49","volume":"31","author":"J Rothenstein","year":"2008","unstructured":"Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, Brierley J, Siu LL. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital. Am J Clin Oncol. 2008;31:64\u201370. https:\/\/doi.org\/10.1097\/COC.0b013e31807a2f49.","journal-title":"Am J Clin Oncol"},{"key":"709_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s12253-011-9382-y","volume":"17","author":"A Caldarella","year":"2011","unstructured":"Caldarella A, Crocetti E, Paci E. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol Oncol Res. 2011;17:759\u201363. https:\/\/doi.org\/10.1007\/s12253-011-9382-y.","journal-title":"Pathol Oncol Res."},{"key":"709_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","volume":"50","author":"T Ito","year":"2015","unstructured":"Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K, Komoto I, Tanaka M, Imamura M, Jensen RT, Takayanagi R, Shimatsu A. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58\u201364. https:\/\/doi.org\/10.1007\/s00535-014-0934-2.","journal-title":"J Gastroenterol."},{"key":"709_CR9","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1002\/ijc.24698","volume":"126","author":"C Lepage","year":"2010","unstructured":"Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G, EUROCARE Working Group. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2010;126:2928\u201334. https:\/\/doi.org\/10.1002\/ijc.24698.","journal-title":"Int J Cancer."},{"key":"709_CR10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","volume":"51","author":"Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M; EUROCARE-5 Working Group","year":"2015","unstructured":"Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, Sant M. EUROCARE-5 Working Group. Survival for oesophageal, stomach and small intestine cancers in Europe 1999\u20132007: results from EUROCARE-5. Eur J Cancer. 2015;51:2144\u201357. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.026.","journal-title":"Eur J Cancer."},{"key":"709_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062487","volume":"8","author":"HJ Tsai","year":"2013","unstructured":"Tsai HJ, Wu CC, Tsai CR, Lin SF, Chen LT, Chang JS. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One. 2013;8: e62487. https:\/\/doi.org\/10.1371\/journal.pone.0062487.","journal-title":"PLoS One."},{"key":"709_CR12","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377.","journal-title":"J Clin Oncol."},{"key":"709_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359. https:\/\/doi.org\/10.1002\/cncr.11105.","journal-title":"Cancer."},{"key":"709_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","volume":"240","author":"MA Maggard","year":"2004","unstructured":"Maggard MA, O\u2019Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117\u201322. https:\/\/doi.org\/10.1097\/01.sla.0000129342.67174.67.","journal-title":"Ann Surg"},{"key":"709_CR15","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/ajg.2010.341","volume":"105","author":"L Ellis","year":"2010","unstructured":"Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010;105:2563\u20139. https:\/\/doi.org\/10.1038\/ajg.2010.341.","journal-title":"Am J Gastroenterol."},{"key":"709_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/1471-2407-10-448","volume":"10","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Kim JW, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Seog Heo D. Bang YJ.\u00a0Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy. BMC Cancer. 2010;10:448. https:\/\/doi.org\/10.1186\/1471-2407-10-448.","journal-title":"BMC Cancer."},{"key":"709_CR17","first-page":"362","volume":"63","author":"W Foltyn","year":"2012","unstructured":"Foltyn W, Zaj\u0119cki W, Marek B, Kajdaniuk D, Siemi\u0144ska L, Zemczak A, Kos-Kud\u0142a B. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. Endokrynol Pol. 2012;63:362\u20136.","journal-title":"Endokrynol Pol."},{"key":"709_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/COC.0b013e31821dee0f","volume":"35","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Kim JW, Oh DY, Han SW, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung). Am J Clin Oncol. 2012;35:549\u201356. https:\/\/doi.org\/10.1097\/COC.0b013e31821dee0f.","journal-title":"Am J Clin Oncol."},{"key":"709_CR19","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.7314\/apjcp.2013.14.11.6687","volume":"14","author":"B Yucel","year":"2014","unstructured":"Yucel B, Babacan NA, Kacan T, Eren AA, Eren MF, Bahar S, Celasun MG, Seker MM, Hasbek Z. Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev. 2014;14:6687\u201392. https:\/\/doi.org\/10.7314\/apjcp.2013.14.11.6687.","journal-title":"Asian Pac J Cancer Prev."}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00709-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-021-00709-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-021-00709-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:19:38Z","timestamp":1667416778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-021-00709-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1007\/s12029-021-00709-8","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"5 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}